Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0LIF stock hub

LON/0LIF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LIFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LIF

In the news

Latest news · LON/0LIF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-33

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LIF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

USD

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	1,371
Employees Change	77%
Employees Change Percent	5.95
Enterprise value	$2.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	US90400D1081
Last refreshed	2026-05-10
Market cap	$1.9B
Price	$26.46
Price currency	USD
Rev Per Employee	370,090.7x
Sic	2836
Symbol	lon/0LIF
Website	https://www.ultragenyx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.5%
EV Earnings	-5.15x
EV/FCF	-6.24x
EV/Sales	4.83x
FCF yield	-20.24%
P/B ratio	-10.85x
P/S ratio	3.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-79.25%
EBITDA Margin	-74.18%
Gross margin	-28.06%
Gross Profit	$-142.4M
Net Income	$-461.2M
Pretax Margin	-90.3%
Profit Margin	-90.9%
Profit Per Employee	$-336,396
ROA	-25.45
Roa5y	-21.76
ROCE	-54.69
Roe5y	-233.6
ROIC	-32.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.47%
Cagr3y	-18.58%
Cagr5y	-25.57%
Revenue Growth	13.43x
Revenue Growth Q	-2.36x
Revenue Growth3 Y	20.4x
Revenue Growth5 Y	14.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.51
Assets	$981.5M
Cash	$312.8M
Debt	$908.8M
Debt FCF	$-2.39
Equity	$-173.4M
Interest Coverage	-7.7
Liabilities	$1.2B
Net Cash	$-504.4M
Net Cash By Market Cap	$-26.8
Tangible Book Value	$-343.8M
Tangible Book Value Per Share	$-3.51
WACC	5.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.02
Inventory Turnover	16.98
Net Working Capital	$-6.8M
Quick ratio	1.65
Working Capital	$251.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.46%
200-day SMA	27.66
3Y total return	-46.03%
50-day SMA	22.78
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.16%
All Time High	169.2
All Time High Change	-84.36%
All Time High Date	2021-02-09
All Time Low	18
All Time Low Change	47%
All Time Low Date	2025-12-29
ATR	1.1
Beta	0.39
Ch YTD	17.52
High	26.55
High52	42
High52 Date	2025-07-09
High52ch	-37%
Low	25.98
Low52	18
Low52 Date	2025-12-29
Low52ch	47%
Ma50ch	16.14%
Price vs 200-day SMA	-4.35%
RSI	67.88
RSI Monthly	41.58
RSI Weekly	51.31
Sharpe ratio	-0.16x
Sortino ratio	-0.13
Total Return	-6.56%
Tr YTD	17.52
Tr1m	15.32%
Tr1w	6.82%
Tr3m	7.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-402.1M
Operating margin	-79.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	94,629,061%
Shares Insiders	3.59%
Shares Institutions	95.26%
Shares Qo Q	0.7%
Shares Yo Y	6.56%
Short Ratio	5.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-489.2M
Average Volume	1,487.4x
Bv Per Share	-1.82
CAPEX	$-4.5M
Ch1m	15.32
Ch1w	6.82
Ch1y	-21.46
Ch3m	7.15
Ch3y	-46.03
Ch5y	-77.16
Ch6m	-11.74
Change	0.61%
Change From Open	1.5
Close	26.3
Days Gap	-0.87
Depreciation Amortization	25,496,946.6
Dollar Volume	6,959
Earnings Date	2026-08-03
EBIT	$-402.1M
EBITDA	$-376.4M
EPS	$-4.63
F Score	3
FCF	$-380.9M
FCF EV Yield	-16.03x
Financing CF	361,991,790
Fiscal Year End	December
Founded	2,010
Income Tax	$3M
Investing CF	50,739,435
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2026-03-31
Ma150	27.15
Ma150ch	-2.53%
Ma20	24.71
Ma20ch	7.1%
Net CF	37,865,250
Next Earnings Date	2026-08-03
Open	26.07
Position In Range	84.21
Price Date	2026-05-08
Relative Volume	0.18x
Revenue	507,394,350x
SBC By Revenue	21.34x
Share Based Comp	108,294,615
Tax By Revenue	0.6x
Tr6m	-11.74%
Volume	263
Z Score	-4.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0LIF pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0LIF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LIF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.3%

Share of float held by funds and institutions

Insider ownership

+3.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LIF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.9

Neutral momentum band

Price vs 200-day MA

-4.3%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LIF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LIF stock rating?

lon/0LIF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LIF analysis?

The full report lives at /stocks/lon/0LIF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LIF?

The latest report frames lon/0LIF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LIF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.